<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, e. g. <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> in the first place, is a common <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in immunocompromised patients </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis of invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is difficult in the absence of confirmation by tissue biopsy and histological studies </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, prevalence of invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> at the School of Medicine of the Leipzig University between 1992 and 1994 was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The diagnosis of invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was suspected on clinical, mycological, and radiological findings </plain></SENT>
<SENT sid="4" pm="."><plain>The definitive diagnosis was obtained by identification of characteristic mould hyphae on stained smears, and/or positive culture, and/or the detection of Aspergillus antigen (Pastorex) in serum, bronchial secretion, or bronchoalveolar fluid, and confirmed by histopathology </plain></SENT>
<SENT sid="5" pm="."><plain>In altogether 21 patients the definitive diagnosis invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was recorded, among them 20 invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergilloses</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Underlying diseases were <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (n = 11), aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (n = 2), non-Hodgkin-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 1), <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (n = 1), kidney transplantation (n = 1), <z:hpo ids='HP_0002586'>peritonitis</z:hpo> after Billroth II anastomosis (n = 1), <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">Polymyalgia rheumatica</z:e> (n = 1), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> plus Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 1), <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> (n = 1), and <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> (n = 1) </plain></SENT>
<SENT sid="7" pm="."><plain>As causative fungi were isolated: Aspergillus fumigatus (n = 13), Aspergillus terreus (n = 1), Aspergillus flavus as rare simultaneous injection with the basidiomycete Coprinus spec. in a leukaemic patient (n = 1), and the dematiaceous fungus Scedosporium prolificans in an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patient with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 1) </plain></SENT>
<SENT sid="8" pm="."><plain>In four patients the invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was confirmed histopathologically without isolation and differentiation of the causative agent </plain></SENT>
<SENT sid="9" pm="."><plain>Nineteen of the 21 patients with invasive mould <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> died corresponding to a mortality rate of 90% </plain></SENT>
</text></document>